Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Konopka-Anstadt, Jennifer L."'
Autor:
Wahid R; PATH, Seattle, WA, USA. rwahid@path.org., Mercer L; PATH, Seattle, WA, USA., Gast C; PATH, Seattle, WA, USA., De Leon T; Hospital Materno Infantil José Domingo De Obaldía, David, Panama.; Centro de Investigación en Vacunas (Cevaxin), Panama City, Panama., Sáez-Llorens X; Centro de Investigación en Vacunas (Cevaxin), Panama City, Panama.; Department of Infectious Diseases at Hospital del Niño Dr. José Renán Esquivel, Sistema Nacional de Investigación at Secretaria Nacional de Ciencia y Tecnologia (SENACYT), Panama City, Panama., Fix A; PATH, Seattle, WA, USA., Macadam A; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Stephens L; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Global Virus Network Center of Excellence, Baltimore, MD, USA., Smits SL; Viroclinics Biosciences B.V, Rotterdam, the Netherlands., Murreddu M; Viroclinics Xplore, Viroclinics Biosciences B.V, Rotterdam, the Netherlands., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Steven Oberste M; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, CA, USA., Bachtiar NS; Research and Development Division, PT. Bio Farma, Bandung, West Java, Indonesia., Tritama E; Research and Development Division, PT. Bio Farma, Bandung, West Java, Indonesia., Bandyopadhyay AS; Bill and Melinda Gates Foundation, Seattle, WA, USA., Aguirre G; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Rüttimann R; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Konz JO; PATH, Seattle, WA, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Feb 11; Vol. 7 (1), pp. 19. Date of Electronic Publication: 2022 Feb 11.
Autor:
Wahid R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. rwahid@path.org., Mercer L; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Macadam A; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Carlyle S; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Stephens L; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Martin J; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Global Virus Network Center of Excellence, Baltimore, MD, USA., Laassri M; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Petrovskaya S; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Smits SL; Viroclinics Biosciences B.V., Rotterdam, the Netherlands., Stittelaar KJ; Viroclinics Xplore, Viroclinics Biosciences B.V., Rotterdam, the Netherlands., Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Weldon WC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Steven Oberste M; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Rüttimann R; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Bandyopadhyay A; Bill and Melinda Gates Foundation, Seattle, WA, USA., Konz J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Jul 29; Vol. 6 (1), pp. 94. Date of Electronic Publication: 2021 Jul 29.
Autor:
Konopka-Anstadt JL; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Campagnoli R; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Vincent A; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Shaw J; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Wei L; 2IHRC, Inc., contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Wynn NT; 3Cherokee Nation Assurance, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Smithee SE; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Bujaki E; 4National Institute for Biological Standards and Control, Hertfordshire, UK., Te Yeh M; 5Department of Microbiology and Immunology, University of California, San Francisco, CA USA., Laassri M; 6Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD USA., Zagorodnyaya T; 6Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD USA., Weiner AJ; 7Bill and Melinda Gates Foundation, Seattle, WA USA., Chumakov K; 6Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD USA.; 8Global Virus Network Center of Excellence, Baltimore MD, USA., Andino R; 5Department of Microbiology and Immunology, University of California, San Francisco, CA USA., Macadam A; 4National Institute for Biological Standards and Control, Hertfordshire, UK., Kew O; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA., Burns CC; 1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2020 Mar 20; Vol. 5 (1), pp. 26. Date of Electronic Publication: 2020 Mar 20 (Print Publication: 2020).